MKI67 and neoplasm: It is speculated that high Ki67 levels in that subset of T cells pre-ICI treatment reflect the active proliferation and metabolic status and obvious immune responses, which are correlated with high tumor burden in the host; therefore, they have been proposed as poor prognostic indicators.